Therapeutic monitoring of isoniazid, rifampicin, ethambutol and pyrazinamide serum levels in the treatment of active pulmonary tuberculosis and determinants of their serum concentrations

Citations Over Time

Abstract

Inadequate serum levels of antimycobacterial drugs have been associated with treatment failure, relapse and acquired drug resistance as well as high concentrations of these drugs may cause intolerance and toxic effects. We objected in this study to determine serum concentrations of anti-tuberculosis drugs and to know the determinants of their concentrations. Venous blood samples was obtained 2 and 6 h after drug ingestion, and serum levels of drugs were analysed using high performance liquid chromatography. Among 49 enrolled active pulmonary tuberculosis patients, the prevalances of a low concentration of isoniazid, rifampicin, ethambutol and pyrazinamide were 28.6, 75.5, 18.4 and 20.4%, respectively. 2 h ısoniazid (INH) concentration was found to be associated with sex (p = 0.005), correlated with body mass index (r = -0.390) and associated with drug dose (mg/kg) (p = 0.000). By Independent samples t-test analysis, low 2 h rifampicin concentration was found to be associated with sex (p = 0.000) and smoking cigarette (p = 0.004). In conclusion, the results of this study have shown that, low 2 h serum INH and rifampicin (RIF) concentration are common and It may be  necessary to optimise drug doses by therapeutic drug monitoring.   Key words: Therapeutic drug monitoring, tuberculosis, isoniazid, rifampicin, ethambutol, pyrazinamide.

Related Papers

• → Protein Binding of First-Line Antituberculosis Drugs(2018)64 cited
• → Plasma Concentrations of Isoniazid and Rifampin Are Decreased in Adult Pulmonary Tuberculosis Patients with Diabetes Mellitus(2013)74 cited
• → Quantification of pyrazinamide, isoniazid, acetyl‐isoniazid, and rifampicin by a high‐performance liquid chromatography method in human plasma from patients with tuberculosis(2020)19 cited
• → Distribution of plasma concentrations of first-line anti-TB drugs and individual MICs: a prospective cohort study in a low endemic setting(2018)21 cited
• → The pharmacokinetics of a single oral or rectal dose of concurrently administered isoniazid, rifampin, pyrazinamide, and ethambutol in Asian elephants (Elephas maximus)(2014)13 cited